top of page
Press Releases
In the News
- Sep 5, 2023
2023 CIMT Annual Meeting Poster Presentation
YB-200, a novel IgG1 antibody targeting CEACAM1/5, induces complete response in syngeneic liver Hepa1-6 tumor-bearing mice and modulates...
- Nov 22, 2022
Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy ...
Authors: Katrin Rupalla, Michel Janicot, Alexej Schmidt, Iris Helfrich, Bernhard B. Singer Full Title: Novel, immune agonistic CEACAM1/5...
- Aug 26, 2020
Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis ...
Authors: Mitsuro Kanda, Dai Shimizu, Koichi Sawaki, Shunsuke Nakamura, Shinichi Umeda, Takashi Miwa, Haruyoshi Tanaka, Chie Tanaka,...
- Mar 13, 2019
Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK ...
Authors: Iris Helfrich and Bernhard B. Singer Full Title: Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its...
- Jul 2, 2018
CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
Authors: Vishal Khairnar, Vikas Duhan, Ashwini M. Patil, Fan Zhou, Hilal Bhat, Christine Thoens, Piyush Sharma, Tom Adomati, Sarah-Kim...
- Oct 5, 2008
CEACAM1 inhibits Toll-like receptor 2–triggered antibact. responses of pulmonary epithelial cells
Authors: Hortense Slevogt, Solveig Zabel, Bastian Opitz, Andreas Hocke, Julia Eitel, Philippe D N'Guessan, Lothar Lucka, Kristian...
bottom of page